Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lyzme5 is a healthcare company specializing in the development of metabolic support supplements for weight management. The company's flagship product, Lyzme5, is a proprietary formulation designed to enhance the body's natural lipid metabolism and fat-burning capabilities. Developed by nutritional biochemist Dr. W.L. Hennen, the product incorporates a blend of lipotropic factors that assist in the breakdown and transport of fats within the body. Lyzme5 targets the consumer wellness market, offering a non-stimulant alternative for individuals seeking to improve their metabolic health. The company emphasizes a science-based approach to nutrition, focusing on ingredients that support liver function and cellular energy processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lyzme5.